vimarsana.com
Home
Live Updates
Late-Breaking Data Presented at the 2023 AAD Annual Meeting
Late-Breaking Data Presented at the 2023 AAD Annual Meeting
Late-Breaking Data Presented at the 2023 AAD Annual Meeting Demonstrates Improved Accuracy of DecisionDx®-SCC in Predicting Metastatic Risk Over Traditional Staging Systems in Independent, Multi-Center Cohort Study
Study data shows consistent independent risk stratification performance of DecisionDx-SCC in a novel cohort of patients with cutaneous squamous cell carcinoma and one or more risk factors
... | March 18, 2023
Related Keywords
United States ,
American ,
Castle Biosciences ,
Instagram ,
American Joint Committee On Cancer ,
Linkedin ,
Castle Biosciences Inc ,
Twitter ,
Nasdaq ,
Orleans Ernestn Morial Convention Center Theater ,
Securities Exchange ,
Facebook ,
Breaking Research ,
New Orleans Ernest ,
About Decisiondx ,
Mypath Melanoma ,
Securities Act ,
Securities Exchange Act ,
Annual Report ,
American Joint Committee ,
Nc Stock Exchange ,
News ,
Information ,
Press Release ,
Study ,
Data ,
Shows ,
Consistent ,
Independent ,
Risk ,
Estratification ,
Performance ,
F ,
N ,
Novel ,
Cohort ,
Patients ,
Ith ,
Cutaneous ,
Squamous ,
Fell ,
Arcinoma ,
End ,
One ,
Dr ,
More ,
Isk Cstl Us14843c1053 ,